Jiangsu Hanbon Science and Technology
688755
ZERUN CO., LTD
301636
SENXUAN
830946
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -34.14%11.06B | -23.42%10.89B | 7.15%14.02B | 17.33%14.72B | 23.18%16.79B | 8.90%14.22B | 14.56%13.09B | 24.35%12.55B | 27.78%13.63B | -30.81%13.06B |
Transactional financial assets | 1,616.83%2.3B | 1,605.28%2.55B | 435.18%1.53B | -32.07%1.05B | -93.69%134.11M | -93.82%149.37M | -87.90%286.72M | -46.64%1.54B | -47.18%2.13B | -48.82%2.42B |
Notes receivable and accounts receivable | 1.71%12.11B | 6.47%10.85B | -3.48%10.59B | 0.45%10.45B | 9.64%11.91B | 3.18%10.19B | 34.54%10.97B | 31.35%10.4B | 30.29%10.86B | 31.50%9.88B |
-Notes receivable | 263.21%1.19B | 308.56%929.65M | -77.75%270.14M | -53.30%346.07M | -68.43%326.87M | -71.18%227.54M | 677.17%1.21B | 389.40%741.1M | 298.50%1.04B | 140.62%789.47M |
-Accounts receivable | -5.67%10.92B | -0.43%9.92B | 5.76%10.32B | 4.58%10.11B | 17.86%11.58B | 9.64%9.97B | 21.99%9.76B | 24.37%9.66B | 21.66%9.83B | 26.52%9.09B |
Other receivables (including interest and dividends) | 44.61%133.22M | 4.21%108.43M | -16.67%103.8M | -31.55%364.96M | -38.40%92.12M | -12.52%104.05M | -36.35%124.57M | 3.69%533.15M | -67.63%149.55M | -27.89%118.95M |
-Dividend receivable | --6.46M | 128.38%10.35M | --5.41M | -32.79%272.91M | ---- | --4.53M | ---- | 45.24%406.03M | ---- | ---- |
-Other receivable | ---- | ---- | ---- | -27.58%92.05M | ---- | -16.33%99.52M | ---- | -45.82%127.11M | ---- | -27.89%118.95M |
Advance payment | -19.83%236.51M | -2.80%303.56M | -46.19%239.75M | -24.70%309.22M | -52.57%295M | -42.48%312.3M | -8.35%445.54M | -18.26%410.64M | -28.07%621.96M | 2.17%542.95M |
Inventories | -2.63%5.97B | -2.29%6.29B | -11.34%6.14B | -14.09%5.99B | -11.69%6.13B | -19.40%6.44B | -22.23%6.92B | -17.25%6.97B | -19.09%6.94B | -4.61%7.99B |
Receivable financing | 9.99%1.98B | 18.67%1.89B | 153.68%2.37B | 171.83%1.72B | 73.12%1.8B | 90.58%1.59B | -46.87%934.28M | -37.70%634.16M | -10.42%1.04B | -27.93%834.67M |
Assets held for sale | --221.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non-current assets due within one year | 116.75%483.93M | 8.47%480.3M | ---- | ---- | 11.53%223.27M | 22.39%442.77M | ---- | ---- | -63.24%200.19M | -32.99%361.77M |
Other current assets | -44.69%940.45M | -72.46%788.11M | -12.93%2.4B | 48.77%1.83B | 36.79%1.7B | 503.38%2.86B | 764.07%2.76B | 75.38%1.23B | 147.72%1.24B | -86.92%474.34M |
Total current assets | -9.31%35.44B | -5.96%34.15B | 5.26%37.4B | 6.32%36.43B | 6.13%39.07B | 1.79%36.32B | 3.38%35.53B | 5.10%34.27B | 3.90%36.82B | -21.60%35.68B |
Non Current assets | ||||||||||
Other equity investment | 0.00%71.75M | 0.00%71.75M | 0.00%71.75M | 0.00%71.75M | 0.00%71.75M | 0.00%71.75M | --71.75M | --71.75M | --71.75M | --71.75M |
Other non-current financial assets | -34.81%198.6M | 19.41%387.69M | -8.54%306.88M | -20.18%312.46M | -20.68%304.65M | -14.74%324.67M | -27.03%335.52M | -11.38%391.45M | -10.82%384.09M | -56.11%380.79M |
Investment real estate | -0.55%45.9M | 13.11%49.88M | -6.86%50.71M | -14.22%47.03M | -16.58%46.15M | -20.99%44.1M | -3.34%54.44M | 10,274.75%54.83M | 10,369.17%55.32M | 10,463.61%55.82M |
Long-term equity investment | 8.43%12.79B | 8.88%12.56B | 3.43%11.93B | 3.85%11.77B | 1.87%11.79B | 1.93%11.54B | 2.86%11.53B | 2.62%11.33B | 269,559.19%11.58B | 6,018.52%11.32B |
Fixed assets | ---- | ---- | ---- | -1.48%2.6B | ---- | -2.17%2.66B | ---- | -8.77%2.64B | ---- | -8.38%2.72B |
Fixed assets liquidation | ---- | ---- | ---- | 28,830.96%117.36K | ---- | -92.88%94.81K | ---- | --405.67 | ---- | --1.33M |
Constru in process | ---- | ---- | ---- | 85.40%713.6M | ---- | 173.06%529.71M | ---- | 32.80%384.91M | ---- | -15.67%193.99M |
Productive biological assets | -18.18%773.55K | -17.39%816.52K | -16.67%859.5K | -16.00%902.47K | -15.38%945.45K | -14.81%988.42K | -14.29%1.03M | -13.79%1.07M | -13.33%1.12M | -12.90%1.16M |
Intangible assets | -3.82%555.41M | -3.70%561.8M | -4.90%561.57M | -3.69%570.98M | -1.90%577.48M | -1.29%583.37M | -9.43%590.5M | -14.10%592.85M | -15.97%588.65M | -15.46%590.99M |
Development expenditure | 51.85%25.58M | 75.90%25.42M | 165.21%24M | 148.52%22.49M | 179.63%16.85M | 139.90%14.45M | --9.05M | --9.05M | --6.02M | --6.02M |
Goodwill | -6.88%96.96M | -6.88%96.96M | -19.83%104.12M | -19.83%104.12M | -19.83%104.12M | -19.83%104.12M | 4.86%129.88M | 4.86%129.88M | -73.10%129.88M | 226.76%129.88M |
Long deferred expense | 14.43%117.77M | 20.64%127.08M | -18.02%86.35M | -13.21%88.31M | 1.40%102.92M | 2.23%105.34M | 222.49%105.33M | 266.62%101.75M | 270.77%101.5M | 304.56%103.04M |
Deferred tax assets | -3.32%752.24M | 9.57%756.98M | 23.52%795.38M | 17.88%798.19M | 8.31%778.06M | -3.14%690.87M | 2.97%643.95M | 15.27%677.12M | 21.60%718.35M | 38.62%713.25M |
Usufruct assets | 10.40%276.08M | 12.72%291.18M | 6.05%270.93M | -0.28%270.26M | -32.19%250.07M | -33.76%258.32M | 10.62%255.47M | 8.88%271.01M | 50.47%368.79M | 47.93%389.98M |
Other non current assets | -75.54%133.85M | -78.51%116.37M | -40.72%572.76M | -43.64%561.89M | -42.00%547.19M | -43.90%541.48M | 20.92%966.21M | 5.54%996.92M | -92.11%943.4M | -6.62%965.22M |
Total non current assets | 5.71%18.82B | 7.41%18.76B | 2.31%18.21B | 1.57%17.93B | -0.65%17.8B | -0.99%17.47B | 2.80%17.8B | 2.09%17.66B | 1.31%17.92B | 158.27%17.64B |
Total assets | -4.61%54.25B | -1.62%52.91B | 4.28%55.61B | 4.70%54.37B | 3.91%56.87B | 0.87%53.78B | 3.19%53.33B | 4.06%51.93B | 3.04%54.73B | 1.88%53.32B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -97.17%48.75M | -75.77%423.38M | -61.76%558.26M | -24.93%1.14B | -7.41%1.72B | -5.60%1.75B | -14.95%1.46B | -16.16%1.52B | -3.39%1.86B | 7.49%1.85B |
Notes payable and accounts payable | 6.05%6.65B | 7.43%6.67B | -3.70%6.36B | -0.74%6.36B | -8.04%6.27B | -6.34%6.21B | -2.53%6.6B | 3.44%6.41B | 2.78%6.82B | 3.01%6.63B |
-Notes payable | 6.65%1.77B | 3.40%1.91B | -3.17%1.76B | -2.00%1.85B | -7.52%1.66B | -7.08%1.85B | -6.39%1.82B | -1.47%1.89B | -11.77%1.8B | -10.63%1.99B |
-Accounts payable | 5.83%4.88B | 9.15%4.76B | -3.90%4.6B | -0.22%4.51B | -8.23%4.61B | -6.03%4.36B | -0.98%4.79B | 5.63%4.52B | 9.23%5.02B | 10.23%4.64B |
Contract liabilities | -0.67%1.73B | 10.13%1.92B | 70.35%2.49B | 13.48%1.76B | -8.79%1.74B | -32.52%1.74B | -12.79%1.46B | 22.87%1.55B | 23.77%1.91B | 7.51%2.58B |
Advance receipts | -24.67%1.25M | -8.21%446.67K | -56.03%1.07M | -36.09%2.05M | 722.11%1.66M | -69.00%486.61K | 188.32%2.43M | 91.91%3.2M | -91.25%201.48K | 9.53%1.57M |
Salaries payable | 14.17%945.68M | 20.31%1.28B | 129.52%862.77M | 132.66%863.1M | 175.15%828.28M | 127.81%1.07B | 80.27%375.9M | 83.13%370.97M | 33.05%301.03M | 56.79%468.45M |
Taxs payable | 40.88%762.25M | 37.37%466.6M | -1.90%492.97M | 8.57%515.23M | -11.87%541.05M | -33.30%339.67M | -19.94%502.53M | -21.54%474.55M | 6.85%613.91M | -4.30%509.29M |
Other payable (including interest and dividends) | 7.40%1.36B | 35.27%1.39B | -5.91%1.33B | 2.95%1.38B | -6.96%1.27B | -1.78%1.03B | 5.19%1.41B | 9.79%1.34B | 6.21%1.36B | 5.38%1.04B |
-Dividend payable | -7.74%79.8M | 0.00%86.49M | 0.08%87.35M | -8.09%87.35M | -3.27%86.49M | -3.27%86.49M | 0.91%87.27M | 9.87%95.03M | 3.38%89.41M | 3.38%89.41M |
-Other payable | ---- | ---- | ---- | 3.80%1.29B | ---- | -1.64%938.6M | ---- | 9.79%1.25B | ---- | 5.58%954.28M |
Non current liabilities due within one year | 3.69%79.79M | 18.33%88.44M | 11.06%84.45M | -13.13%68.74M | -23.50%76.95M | -20.38%74.74M | -21.36%76.05M | -15.42%79.13M | 28.87%100.59M | -6.74%93.87M |
Other current liabilities | -60.70%658.63M | 16.50%620.86M | 272.05%1.73B | 262.88%1.7B | 228.63%1.68B | 39.81%532.94M | 128.04%464.78M | 210.35%468.01M | 147.57%509.96M | 60.69%381.19M |
Total current liabilities | -13.36%12.24B | 0.95%12.86B | 12.53%13.9B | 12.87%13.8B | 4.81%14.13B | -6.05%12.74B | -2.28%12.36B | 5.80%12.22B | 8.06%13.48B | 6.60%13.56B |
Current liabilities | ||||||||||
Long term loan | 0.00%2.1M | 0.00%2.1M | 0.00%2.1M | 0.00%2.1M | 0.00%2.1M | 0.00%2.1M | -97.53%2.1M | -97.53%2.1M | -98.00%2.1M | -97.66%2.1M |
Long term account payable | ---- | ---- | ---- | -3.95%607.38M | ---- | -2.24%626.9M | ---- | -1.81%632.34M | ---- | -0.44%641.24M |
Long term salaries pay | -65.86%1.39M | -68.31%1.3M | -2.23%4.02M | -4.53%4.04M | -4.48%4.07M | -4.43%4.09M | -6.37%4.11M | -4.03%4.24M | -4.45%4.26M | -4.36%4.28M |
Specific account payable | ---- | ---- | ---- | 0.00%4.84M | ---- | 0.00%4.84M | ---- | 0.00%4.84M | ---- | 0.00%4.84M |
Estimate liabilities | --33.59M | --12.73M | --13.76M | --16.05M | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax liabilities | 40.22%109.38M | 25.54%93.87M | 32.31%74.42M | 31.04%91.31M | -4.34%78M | -23.76%74.77M | 164.73%56.24M | 254.35%69.68M | 240.26%81.55M | 54.06%98.08M |
Long term deferred income | 16.80%299.34M | 23.74%295.49M | 45.80%279.8M | 38.61%258.3M | 40.30%256.3M | 33.70%238.81M | -0.06%191.91M | -6.11%186.34M | -7.66%182.68M | -10.32%178.62M |
Lease liabilities | 12.59%187.35M | 10.62%190.66M | 4.40%183.22M | 5.17%193.46M | -37.13%166.4M | -39.69%172.35M | 1.23%175.49M | -5.13%183.95M | 43.17%264.67M | 68.08%285.78M |
Other non current liabilities | -85.45%1.93M | -88.83%1.93M | -91.11%1.93M | -91.03%1.93M | -37.08%13.28M | -16.23%17.3M | 1,024.61%21.72M | 1,014.96%21.54M | 992.49%21.1M | 969.01%20.65M |
Total non current liabilities | 6.51%1.22B | 4.25%1.19B | 6.97%1.17B | 6.73%1.18B | -4.89%1.14B | -7.64%1.14B | -3.34%1.09B | -4.45%1.11B | 3.12%1.2B | 4.54%1.24B |
Total liabilities | -11.87%13.46B | 1.22%14.05B | 12.08%15.07B | 12.36%14.98B | 4.02%15.27B | -6.19%13.88B | -2.37%13.44B | 4.87%13.33B | 7.63%14.68B | 6.43%14.79B |
Shareholders equity | ||||||||||
Paid-in capital | -0.70%1.78B | -0.70%1.78B | -0.70%1.78B | -0.70%1.78B | 0.00%1.8B | 0.00%1.8B | 0.00%1.8B | 0.00%1.8B | 40.05%1.8B | 40.08%1.8B |
Capital reserve funds | -3.33%17.64B | -3.34%17.64B | -3.59%17.58B | -3.67%17.57B | 0.07%18.25B | 0.08%18.25B | -0.20%18.23B | -0.15%18.24B | 0.48%18.23B | 0.58%18.23B |
Surplus reserve funds | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B | 0.00%2.53B |
Retained profit | -4.48%18.92B | -6.19%16.98B | 3.26%18.72B | 4.45%17.59B | 8.58%19.8B | 8.26%18.1B | 13.16%18.13B | 10.63%16.84B | 6.05%18.24B | 2.67%16.72B |
Less:Treasury stock | ---- | ---- | ---- | ---- | 0.00%707.43M | 0.00%707.43M | 0.00%707.43M | 0.00%707.43M | --707.43M | --707.43M |
Other composite income | -11.80%-101.23M | -13.10%-101.26M | 5.70%-94.45M | -2.39%-97.91M | -43.04%-90.55M | -31.50%-89.54M | -14.95%-100.16M | -174.44%-95.63M | -1,777.65%-63.3M | -2,808.55%-68.09M |
Shareholders equity without minority interests | -1.95%40.77B | -2.63%38.83B | 1.59%40.52B | 2.00%39.37B | 3.87%41.58B | 3.57%39.88B | 5.44%39.89B | 4.13%38.6B | 2.23%40.03B | 0.72%38.5B |
Minority interests | 14.78%26.86M | 30.11%34.14M | 1,641.77%21.01M | 1,515.51%20.89M | 2.48%23.4M | 12.50%26.24M | -98.60%1.21M | -101.21%-1.48M | -92.99%22.83M | -88.77%23.32M |
Total shareholder equity | -1.94%40.79B | -2.60%38.87B | 1.64%40.54B | 2.06%39.39B | 3.87%41.6B | 3.58%39.91B | 5.21%39.89B | 3.78%38.6B | 1.45%40.05B | 0.24%38.53B |
Total liabilityies and equity | -4.61%54.25B | -1.62%52.91B | 4.28%55.61B | 4.70%54.37B | 3.91%56.87B | 0.87%53.78B | 3.19%53.33B | 4.06%51.93B | 3.04%54.73B | 1.88%53.32B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.